We are live on
!
Find out more
AA
AlphaCentric Advisors Portfolio holdings
AUM
$100M
This Fund
S&P 500
This Quarter
Est. Return
+3.46%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$343M
AUM Growth
-$50.3M
(-13%)
Cap. Flow
-$56.3M
Cap. Flow
% of AUM
-16.41%
Top 10 Holdings %
Top 10 Hldgs %
78.35%
Holding
286
New
92
Increased
41
Reduced
68
Closed
66
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$1.84M |
| 2 |
Jazz Pharmaceuticals
JAZZ
|
+$1.31M |
| 3 |
GXO Logistics
GXO
|
+$1.26M |
| 4 |
Aurora
AUR
|
+$1.11M |
| 5 |
Puma Biotechnology
PBYI
|
+$1.09M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Mortgage-Backed Securities ETF
VMBS
|
+$30.4M |
| 2 |
iShares MBS ETF
MBB
|
+$29.8M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
+$1.86M |
| 4 |
Azenta
AZTA
|
+$1.53M |
| 5 |
Synopsys
SNPS
|
+$1.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Real Estate | 24.12% |
| 2 | Healthcare | 12.62% |
| 3 | Financials | 1.65% |
| 4 | Technology | 1.41% |
| 5 | Industrials | 1.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
iShares MBS ETF
MBB
$39.3B
| $111M | 32.34% |
1,033,000
-277,000
| -21% | -$29.8M |
|
|
2
Vanguard Mortgage-Backed Securities ETF
VMBS
$15.5B
| $69.9M | 20.36% |
1,322,000
-573,000
| -30% | -$30.4M |
|
3
Invitation Homes
INVH
$17.9B
| $38.7M | 11.29% |
854,144
| – | – |
|
4
American Homes 4 Rent
AMH
$12.3B
| $35.2M | 10.26% |
806,924
| – | – |
|
|
5
iShares 1-3 Year Treasury Bond ETF
SHY
$25.7B
| $3.85M | 1.12% |
45,066
+21,441
| +91% | +$1.84M |
|
6
Rithm Capital
RITM
$5.2B
| $2.63M | 0.77% |
245,158
| – | – |
|
7
Stereotaxis
STXS
$154M
| $2.33M | 0.68% |
375,000
+25,000
| +7% | +$149K |
|
8
Omnicell
OMCL
$2.09B
| $1.8M | 0.53% |
10,000
| – | – |
|
9
Intuitive Surgical
ISRG
$122B
| $1.8M | 0.52% |
5,000
-250
| -5% | -$86K |
|
|
LKFT
10
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.97B
| $1.71M | 0.5% |
31,000
+1,500
| +5% | +$78.3K |
|
|
ARNA
11
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $1.53M | 0.45% |
16,500
| – | – |
|
12
Ametek
AME
$54.3B
| $1.47M | 0.43% |
10,000
| – | – |
|
13
Incyte
INCY
$23.4B
| $1.47M | 0.43% |
20,000
+4,750
| +31% | +$320K |
|
|
MOR
14
DELISTED
MorphoSys AG American Depositary Shares
MOR
| $1.37M | 0.4% |
145,500
+44,500
| +44% | +$472K |
|
15
Allient
ALNT
$1.49B
| $1.37M | 0.4% |
37,500
| – | – |
|
|
ZGNX
16
DELISTED
Zogenix, Inc.
ZGNX
| $1.34M | 0.39% |
82,500
+17,500
| +27% | +$256K |
|
17
Accuray
ARAY
$30.8M
| $1.31M | 0.38% |
275,000
+25,000
| +10% | +$121K |
|
18
Vuzix
VUZI
$188M
| $1.3M | 0.38% |
150,000
+50,000
| +50% | +$540K |
|
|
19
Jazz Pharmaceuticals
JAZZ
$15.5B
| $1.27M | 0.37% |
+10,000
| New | +$1.31M |
|
|
20
GXO Logistics
GXO
$6.22B
| $1.27M | 0.37% |
+14,000
| New | +$1.26M |
|
|
21
Puma Biotechnology
PBYI
$434M
| $1.22M | 0.35% |
400,000
+251,500
| +169% | +$1.09M |
|
22
Acadia Pharmaceuticals
ACAD
$4.38B
| $1.2M | 0.35% |
51,500
-22,000
| -30% | -$442K |
|
|
CYBE
23
DELISTED
Cyberoptics Corp
CYBE
| $1.16M | 0.34% |
25,000
| – | – |
|
24
MP Materials
MP
$8.05B
| $1.14M | 0.33% |
+25,000
| New | +$985K |
|
|
EFC
25
Ellington Financial
EFC
$1.7B
| $1.13M | 0.33% |
66,283
+6,000
| +10% | +$107K |
|
Similar funds
WCM
FCM
BIA
AGAM
E
HCM
AC
OIS
AlphaCentric Advisors's Q4 2021 Portfolio in Review
As of Q4 2021, AlphaCentric Advisors held 286 positions worth $343M, down 13% from $393M the previous quarter. Its ten largest holdings account for 78% of the portfolio.
AlphaCentric Advisors withdrew a net $56.3M in Q4 2021, closing 66 positions and reducing 68 holdings. Its most notable exit was Vertex Pharmaceuticals, an estimated $1.86M position sold in full.
By sector, the portfolio is most concentrated in Real Estate at 24% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.
Against the trend, AlphaCentric Advisors opened a new position in Jazz Pharmaceuticals worth $1.27M.
- AlphaCentric Advisors's largest Q4 2021 buy was Jazz Pharmaceuticals: 10,000 shares worth $1.27M.
- AlphaCentric Advisors added most to iShares 1-3 Year Treasury Bond ETF in Q4 2021, an estimated $1.84M increase.
- AlphaCentric Advisors's biggest Q4 2021 reduction was Vanguard Mortgage-Backed Securities ETF, cutting an estimated $30.4M.
- AlphaCentric Advisors fully exited Vertex Pharmaceuticals in Q4 2021, selling an estimated $1.86M.
- AlphaCentric Advisors's ten largest holdings make up 78% of its $343M portfolio in Q4 2021.
- AlphaCentric Advisors opened 92 new positions and closed 66 in Q4 2021.
- AlphaCentric Advisors's portfolio value fell 13% quarter-over-quarter to $343M.
Based on AlphaCentric Advisors's 13F filing for Q4 2021, filed 25 Feb 2022.